NCT01612143 A Relative Bioavailability Study of Setrobuvir Tablet Formulation Versus Reference Setrobuvir Capsule Formulation in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01610791 A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs (REMISSION) Status COMPLETED Phase PHASE3
NCT01609543 A Study of Tarceva (Erlotinib) in First Line in Patients With Locally Advanced or Metastatic Lung Adenocarcinoma With EGFR Mutations Status COMPLETED Phase PHASE4
NCT01609075 An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer in Italy (BEWARE) Status COMPLETED Phase N/A
NCT01609049 An Observational Study of Peginterferon Alfa-2a in Combination With Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver Cirrhosis Status COMPLETED Phase N/A
NCT01609036 An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Follicular Lymphoma Status TERMINATED Phase N/A
NCT01609023 A Study of Rituximab (MabThera) in Combination With Chemotherapy in Participants With CD20-Positive B-Cell Chronic Lymphocytic Leukemia Status COMPLETED Phase N/A
NCT01609010 A Study of MabThera/Rituxan (Rituximab) Alone and in Combination With Roferon-A in Patients With Follicular or Other CD20+ Low-Grade (Indolent) Lymphoma Status COMPLETED Phase PHASE3
NCT01606098 The Role of Surgery of the Primary Tumour in Patients With Synchronous Unresectable Metastases of Colorectal Cancer Status COMPLETED Phase PHASE3
NCT01605526 A Study of RO5045337 in Combination With Doxorubicin in Patients With Soft Tissue Sarcoma Status COMPLETED Phase PHASE1
NCT01604291 An Observational Study of Dual and Triple Therapies Based on Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis C Status COMPLETED Phase N/A
NCT01598285 A Combined GWAS and miRNA for the Identification of Bevacizumab Response Predictors in Metastatic Breast Cancer Status TERMINATED Phase N/A
NCT01597414 Elderly Metastatic Breast Cancer: Pertuzumab-Herceptin vs Pertuzumab-Herceptin-Metronomic Chemotherapy, Followed by T-DM1 Status COMPLETED Phase PHASE2
NCT01592890 A Study of The Excretion Balance, Pharmacokinetics and Metabolism of A Single Oral Dose of [14C]-Labeled RO4917523 in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT01592331 A Pharmacodynamic and Pharmacokinetic Study of RO5508887 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01592318 A Study of The Relative Bioavailability of Ritonavir-Boosted Danoprevir Fixed Dose Combination Tablets in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01592305 A Study of Drug-Drug Interaction Between Danoprevir Coadministered With Low-Dose Ritonavir and Tenofovir Disoproxil Fumarate or Atazanavir Status COMPLETED Phase PHASE1
NCT01592292 An Observational Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis And Inadequate Response Or Intolerance to a First Anti-TNF Alpha Therapy Status COMPLETED Phase N/A
NCT01591850 A Drug-Drug Interaction Study of Ketoconazole, Rifampicin and Ritonavir-Boosted Atazanavir With Single-Dose RO5093151 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01591460 A Triple Combination Therapy Study of Boceprevir, Pegasys and Copegus in Previously Untreated Patients With Genotype 1 Chronic Hepatitis C Status COMPLETED Phase PHASE4